ECMO: Back where we Started,Again

Kammemeyer K. Silicone rubber as a selective barrier. Indian Eng Chem 1957; 49: 1685.

Kolobow T. , Bowman R. Construction and evaluation of an alveolar membrane artificial heart lung. Trans ASAIO 1963; 50: 29.

Hill D. , O'Brien T. , Muarry J. Extracorporeal oxygenation for acute post traumatic respiratory failure (shock-lung syndrome) Use of the Bramson membrane lung. N Engl J Med 1972; 286: 629–34.

Bartlett R. , Andrews A. , Toomasian J. , Haidue H. , Gazzangia A. Extracorporeal Membrane Oxygenation (ECMO) in neonatal respiratory failure: 45 cases. Surgery 1982; 92: 425–53.

O'Rourke P. , Krone R. , Vacanti J. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study. Pediatr 1989; 84: 957–63.

Bartlett R. , Roloff D. , Cornell R. Extracoporeal circulation in neonatal respiratory failure: A prospective randomized study. Pediatr 1985; 4: 479–87.

ECMO Registry of the Extracorporeal Life Support Organization (ELSO). Ann Arbor, Michigan: January, 2005.

Zapol W. , Snider M. , Hill J. Extracorporeal membrane oxygenation in severe respiratory failure. JAMA 1979; 242: 2193–6.

Barefield E. , Karle V. , Phillips J. , Carlo W. Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996; 129: 279–86.

The INOS Study Group: Inhaled nitric oxide for near term infants with respiratory failure. New Engl J Med 1997; 336: 602–5.

Davidson D, Barefield E, Kattwinkel J, Dudell G, Damask G, Straube R, Rhines J, and the INO/PPHN Study Group. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double masked, placebo controlled, dose response, multicenter study. Pediatr 1998; 101: 325–34.

Auten R. , Notter R. , Kendig J. , Davis J. , Shapiro D. Surfactant treatment of full-term newborns with respiratory failure. Pediatr 1991; 87: 101–07.

Khammash H. , Perlman M. , Wojtulewicz J. , Dunn M. Surfactant therapy in full term neonates with severe respiratory failure. Pediatr 1993; 92: 135–9.

Findlay R. , Taeusch H. , Walther F. Surfactant replacement therapy for meconium aspiration syndrome. Pediatr 1996; 97: 48–52.

Lotze A. , Mitchell B. , Bulas D. , Zola E. , Shalwitz R. , Gunkel J. Multicenter study of surfactant (beractant) use in the treatment of term in the treatment of term infants with severe respiratory failure. J Pediatr 1998; 132: 40–7.

Carlo W. , Beoglos A. , Chatburn R. , Walsh M. , Martin R. High-frequency jet ventilation in neonatal pulmonary hypertension. AJDC 1989; 124: 447–54.

Clark R. , Yoder B. , Sell M. Prospective randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994; 124: 447–54.

Goodman D. , Green T. Extracorporeal life support for children with acute respiratory distress syndrome. In: Zwischenberger J. , Steinhorn R. , Bartlett R. , eds. ECMO extracorporeal cardiopulmonary support in critical care. Extracorporeal Life Support Organization 2000; p. 421.

Spanier T. , Chen J. , Oz M. Selective anticoagulation with active site-blocked factor IXa suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998; 116: 860–9.

Hilt T. , Bayat M. Drugs used to limit blood surface interactions. Crit Care Nurs Clin N Am 2002; 14: 7–16.

Hidchiko I. , Koichi Y. , Yukihiko N. Development of the oxygenator: Past present and future. Int J Artif Organs 2004; 7: 111–20.

Tadashi M. , Tomohiro M. , Shiniji K. Development of silicone rubber hollow fiber oxygenator for ECMO. Artif Organs 2003; 27: 1050–6.

Kihara S. , Kawai A. , Endo M. , Koyangi H. , Kurosawa H. Extracorporeal membrane oxygenation and left ventricular assist device: A case of double mechanical bridge. Heart Vessels 2002; 16: 164–6.

Marcolin R. , Bombino M. , Fumagalli R. Veno-venous ELS with heparin bonded circuits. Int J Artif Organs 1995; 18: 624–6.

Gravel M. , Arenas J. , Chenault R. Kidney transplantation from organ donors following cardiopulmonary death using extracorporeal membrane oxygenation support. Ann Transplant 2004; 9: 57–8.

Ludwig K. , von Segesser . Heparin-bonded surfaces in Extracorporeal membrane oxygenation for cardiac support. Ann Thorac Surg 1996; 61: 330–5.

Johnston N. , Wait M. , Huber L. Agratoban in adult extracorporeal membrane oxygenation. J Extra Corpor Technol 2002; 34: 281–4.

Dager W. , Gosselin R. , Yoshikawa R. , Owings J. Lepuridin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation. Ann Phamacother 2004; 38: 698–604.

Young G. , Yonekawa K. , Nakagawa P. , Nugent D. Agratoban as an alternative to heparin in extracorporeal membrane oxygenation circuits. Perfusion 2004; 19: 283–8.

Sheehy E. , Conrad S.L. , Brigham L.E. Estimating the number of potential organ donors in the United States. N Engl J Med 2003; 349: 667–74.

Conrad S. , Zwischenberger J. , Grier L. , Bidani A. Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: A phase 1 clinical study. Intensive Care Med 2001; 27: 1340–51.

Bein T. , Prasser C. , Philipp A. , Muller T. Pumpless extracorporeal lung assist using arterio-venous shunt in severe ARDS. Experience with 30 cases. Anaesthesist 2004; 53: 813–9.

Jayroe J. , Alpard S. , Wang D. , Deyo D. Hemodynamic stability during arteriovenous carbon dioxide removal for adult respiratory distress syndrome: A prospective randomized outcomes study in adult sheep. ASAIO J 2001; 47: 211–4.

Gott V. , Whiffen J. , Dutton R. Heparin bonding on colloidal graphite surfaces. Science 1963; 142: 1297–8.

Muntean W. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Int J Artif Organs 1999; 23: 979–83.

Montoya J. , Merz S. , Bartlett R. Significant safety advantages gained with an improved pressure regulated pump. J Extra Corpor Technol 1996; 28: 71–8.

Zwischenberger J.B. , Nguyen T.T. , Upp J.R. Jr. , Bush P.E. , Cox C.S. Jr. , Delosh T. , Broemling L. Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg 1994; 107: 838–48.

Warkentin T.E. , Levine M.N. , Hirsh J. , Horsewood P. , Roberts R.S. , Gent M. , Kelton J.G. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330–5.

Nagaya M. , Futamura M. , Kato J. , Niimi N. , Fukuta S. Application of a new anticoagulant (nafamostat mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation – a preliminary report. J Pediatr Surg 1997; 32: 531–5.

UK Collaborative ECMO Trial Group. UK collaborative randomized trial of neonatal extracorporeal membrane oxygenation. Lancet 1996; 348: 75–81.

Lick S. , Zwischenberger J. Artificial lung: Bench towards bedside. ASAIO J 2004; 50: 2–5.

Haft J. , Montoya P. , Alnajjar O. , Posner S. An artificial lung reduces pulmonary impedance and improves right ventricular efficiency in pulmonary hypertension. J Thorac Cardiovasc Surg 2001; 122: 1094–100.

Haft J. , Bull J. , Rose R. , Katsra J. , Grotberg J. , Bartlett R. , Hirschl R. Design of an artificial lung compliance chamber for pulmonary replacement. ASAIO J 2003; 49: 35–40.

Zwischenberger JB. , Wang D. , Lick SD. , Deyo DJ. , Alpard SK. , Chambers S.D. The paracorporeal artificial lung improves 5-day outcomes from lethal smoke/burn-induced acute respiratory distress syndrome in sheep. Ann Thorac Surg 74: 1011–6.

Lick S.D. , Zwischenberger J.B. , Alpard S.K. , Witt S.A. , Deyo D.M. , Merz S.I. Development of an ambulatory artificial lung in an ovine survival model. ASAIO J 2001; 47: 486–91.

Lick S.D. , Zwischenberger J.B. , Wang D. , Deyo D.J. , Alpard S.K. , Chambers S.D. Improved right heart function with a compliant inflow artificial lung in series with the pulmonary circulation. Ann Thorac Surg 2001; 72: 899–904.